Significant effect of polymorphisms in CYP2D6 on response to tamoxifen therapy for breast cancer: A prospective multicenter study

by Zembutsu H., Nakamura S., Akashi-Tanaka S., Kuwayama T., Watanabe C., Takamaru T., Takei H., Ishikawa T., Miyahara K., Matsumoto H., Hasegawa Y., Kutomi G., Shima H., Satomi F., Okazaki M., Zaha H., Onomura M., Matsukata A., Sagara Y., Baba S., Yamada A., Shimada K., Shimizu D., Tsugawa K., Shimo A., Tan E.Y., Hartman M., Chan C.-W., Lee S.C., Nakamura Y.
Published 2018

A genome-wide association study identifies three novel genetic markers for response to tamoxifen: A prospective multicenter study

by Onishi H., Udagawa C., Kubo M., Nakamura S., Akashi-Tanaka S., Kuwayama T., Watanabe C., Takamaru T., Takei H., Ishikawa T., Miyahara K., Matsumoto H., Hasegawa Y., Momozawa Y., Low S.-K., Kutomi G., Shima H., Satomi F., Okazaki M., Zaha H., Onomura M., Matsukata A., Sagara Y., Baba S., Yamada A., Shimada K., Shimizu D., Tsugawa K., Shimo A., Hartman M., Chan C.-W., Lee S.C., Endo I., Zembutsu H.
Published 2019

Significant Effect of Polymorphisms in CYP2D6 on Response to Tamoxifen Therapy for Breast Cancer: A Prospective Multicenter Study

by Zembutsu, Hitoshi, Nakamura, Seigo, Akashi-Tanaka, Sadako, Kuwayama, Takashi, Watanabe, Chie, Takamaru, Tomoko, Takei, Hiroyuki, Ishikawa, Takashi, Miyahara, Kana, Matsumoto, Hiroshi, Hasegawa, Yoshie, Kutomi, Goro, Shima, Hiroaki, Satomi, Fukino, Okazaki, Minoru, Zaha, Hisamitsu, Onomura, Mai, Matsukata, Ayami, Sagara, Yasuaki, Baba, Shinichi, Yamada, Akimitsu, Shimada, Kazuhiro, Shimizu, Daisuke, Tsugawa, Koichiro, Shimo, Arata, Tan, Ern Yu, Hartman, Mikael, Chan, Ching-Wan, Lee, Soo Chin, Nakamura, Yusuke
Published 2021